BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 21669562)

  • 1. New adipocytokines (vaspin, apelin, visfatin, adiponectin) levels in children treated with valproic acid.
    Meral C; Cekmez F; Vurucu S; Tascılar E; Pirgon O; Canpolat FE; Ipcioglu OM; Aydemir G; Aydınoz S
    Eur Cytokine Netw; 2011 Jun; 22(2):118-22. PubMed ID: 21669562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apelin, vaspin, visfatin and adiponectin in large for gestational age infants with insulin resistance.
    Cekmez F; Canpolat FE; Pirgon O; Çetinkaya M; Aydinoz S; Suleymanoglu S; Ipcioglu OM; Sarici SU
    Cytokine; 2011 Nov; 56(2):387-91. PubMed ID: 21742512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adiponectin and visfatin concentrations in children treated with valproic acid.
    Rauchenzauner M; Haberlandt E; Scholl-Bürgi S; Ernst B; Hoppichler F; Karall D; Ebenbichler CF; Rostasy K; Luef G
    Epilepsia; 2008 Feb; 49(2):353-7. PubMed ID: 18070089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum visfatin and vaspin levels in prepubertal children: effect of obesity and weight loss after behavior modifications on their secretion and relationship with glucose metabolism.
    Martos-Moreno GÁ; Kratzsch J; Körner A; Barrios V; Hawkins F; Kiess W; Argente J
    Int J Obes (Lond); 2011 Oct; 35(10):1355-62. PubMed ID: 21266955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of adipocytokines in obese children with insulin resistance.
    Taşçilar ME; Cekmez F; Meral C; Pirgon O; Tanju IA; Canpolat FE; Abaci A; Tapan S; Eker I
    Turk J Pediatr; 2011; 53(3):269-73. PubMed ID: 21980807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of new adipocytokines and insulin resistance in adolescents with polycystic ovary syndrome.
    Cekmez F; Cekmez Y; Pirgon O; Canpolat FE; Aydinöz S; Metin Ipcioglu O; Karademir F
    Eur Cytokine Netw; 2011 Mar; 22(1):32-7. PubMed ID: 21411410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluate the effects of long-term valproic acid treatment on metabolic profiles in newly diagnosed or untreated female epileptic patients: A prospective study.
    Sidhu HS; Srinivas R; Sadhotra A
    Seizure; 2017 May; 48():15-21. PubMed ID: 28365440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of topiramate and valproate therapy on insulin, c-peptide, leptin, neuropeptide Y, adiponectin, visfatin, and resistin levels in children with epilepsy.
    Sonmez FM; Zaman D; Aksoy A; Deger O; Aliyazicioglu R; Karaguzel G; Fazlioglu K
    Seizure; 2013 Dec; 22(10):856-61. PubMed ID: 23937963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of rosiglitazone and metformin treatment on apelin, visfatin, and ghrelin levels in patients with type 2 diabetes mellitus.
    Kadoglou NP; Tsanikidis H; Kapelouzou A; Vrabas I; Vitta I; Karayannacos PE; Liapis CD; Sailer N
    Metabolism; 2010 Mar; 59(3):373-9. PubMed ID: 19815243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of circulating adipocytokines vaspin, apelin, and visfatin in the loss of appetite in underweight children: a pilot trial.
    Vehapoglu A; Ustabas F; Ozgen TI; Terzioglu S; Cermik BB; Ozen OF
    J Pediatr Endocrinol Metab; 2015 Sep; 28(9-10):1065-71. PubMed ID: 25915077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-related metabolic changes during treatment with valproate in patients with epilepsy.
    Pylvänen V; Pakarinen A; Knip M; Isojärvi J
    Epilepsy Behav; 2006 May; 8(3):643-8. PubMed ID: 16600693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of valproic acid treatment on body composition, leptin and the soluble leptin receptor in epileptic children.
    Rauchenzauner M; Haberlandt E; Scholl-Bürgi S; Karall D; Schoenherr E; Tatarczyk T; Engl J; Laimer M; Luef G; Ebenbichler CF
    Epilepsy Res; 2008 Aug; 80(2-3):142-9. PubMed ID: 18472247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaspin and its correlation with insulin sensitivity indices in obese children.
    Suleymanoglu S; Tascilar E; Pirgon O; Tapan S; Meral C; Abaci A
    Diabetes Res Clin Pract; 2009 Jun; 84(3):325-8. PubMed ID: 19356820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of rosiglitazone/metformin fixed-dose combination therapy and metformin monotherapy on serum vaspin, adiponectin and IL-6 levels in drug-naïve patients with type 2 diabetes.
    Kadoglou NP; Kapelouzou A; Tsanikidis H; Vitta I; Liapis CD; Sailer N
    Exp Clin Endocrinol Diabetes; 2011 Feb; 119(2):63-8. PubMed ID: 21031343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin resistance in patients on valproic acid: relation to adiponectin.
    Aly RH; Amr NH; Saad WE; Megahed AA
    Acta Neurol Scand; 2015 Mar; 131(3):169-75. PubMed ID: 25286962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma visfatin concentrations increase in both hyper and hypothyroid subjects after normalization of thyroid function and are not related to insulin resistance, anthropometric or inflammatory parameters.
    Caixàs A; Tirado R; Vendrell J; Gallart L; Megía A; Simón I; Llauradó G; González-Clemente JM; Giménez-Palop O
    Clin Endocrinol (Oxf); 2009 Nov; 71(5):733-8. PubMed ID: 19222486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polycystic ovaries, obesity and insulin resistance in women with epilepsy. A comparative study of carbamazepine and valproic acid in 105 women.
    Luef G; Abraham I; Haslinger M; Trinka E; Seppi K; Unterberger I; Alge A; Windisch J; Lechleitner M; Bauer G
    J Neurol; 2002 Jul; 249(7):835-41. PubMed ID: 12140666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating visfatin in obese non-diabetic patients in relation to cardiovascular risk factors, insulin resistance, and adipocytokines: a contradictory piece of the puzzle.
    de Luis DA; Sagrado MG; Aller R; Conde R; Izaola O
    Nutrition; 2010; 26(11-12):1130-3. PubMed ID: 19211226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating levels of novel adipocytokines in patients with colorectal cancer.
    Fazeli MS; Dashti H; Akbarzadeh S; Assadi M; Aminian A; Keramati MR; Nabipour I
    Cytokine; 2013 Apr; 62(1):81-5. PubMed ID: 23474107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum levels of novel adipokines in patients with acute ischemic stroke: potential contribution to diagnosis and prognosis.
    Kadoglou NP; Fotiadis G; Lambadiari V; Maratou E; Dimitriadis G; Liapis CD
    Peptides; 2014 Jul; 57():12-6. PubMed ID: 24768795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.